Yasuyoshi Yamamoto

Lack of interleukin‐2 (IL‐2) expression and selective expression of IL‐10 mRNA in human renal cell carcinoma

E. Halapi, R. Kiessling, C. Juhlin, 1995, International journal of cancer.

Cytotoxic activity and T cell receptor repertoire in tumor-infiltrating lymphocytes of adrenal cell carcinomas

E. Halapi, R. Kiessling, C. Juhlin, 1993, Cancer Immunology, Immunotherapy.

Restricted T cell receptor V-β and J-β usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomas

E. Halapi, R. Kiessling, H. Mellstedt, 2005, Cancer Immunology, Immunotherapy.

PANCERATIC CARCINOMA WITH GIANT SPLENIC METASTASIS-A CASE REPORT-

H. Fujii, Y. Matsumoto, M. Yoshioka, 1994 .

Study on I . Lymphokine Activated Killer ( LAK ) Improved LAK cell induction in vitTo Cells

H. Fujii, H. Nukui, Y. Iimuro, 2010 .

A Proposal of Effctive Immunochemotherapy Using Recombinant Interleukin 2 and Adriamycin, and Its Theoretical Background

H. Iizuka, K. Tasaka, Yasuyoshi Yamamoto, 1990 .